Skip to content

VenoPlus 8 Review: What the Nitric Oxide Research Actually Supports

Affiliate disclosure: This article contains affiliate links. If you buy through them, we may earn a commission at no extra cost to you. This does not influence our assessment of the evidence below.

Evidence rating: Moderate — the core circulation ingredients have meta-analysed randomized trials behind them, with effect sizes that are real but small

What VenoPlus 8 Claims To Be

VenoPlus 8 is positioned as a heart and circulation drink mix built around nitric oxide. The underlying idea is one of the better-established stories in vascular physiology: nitric oxide is the signalling molecule that tells the smooth muscle lining your arteries to relax, and the body makes less of it with age. Supplement makers approach this from two directions — supplying amino acid precursors the body converts into nitric oxide, and supplying dietary nitrate that gut bacteria reduce into it.

VenoPlus 8 does both, which is a sensible design choice rather than a gimmick.

What’s Actually In It

The formula is broad. The named ingredients include:

  • L-citrulline and L-arginine — the nitric oxide precursor pathway
  • RedNite beetroot extract — the dietary nitrate route
  • MenaQ7 vitamin K2 (MK-7) — a branded menaquinone-7
  • Pomella pomegranate extract, grape seed extract, hesperidin, horse chestnut seed extract
  • CoQ10, omega-3 fatty acids, magnesium, vitamin C, taurine
  • Garlic, ginger root and green tea extracts

Three of those are branded, standardized raw materials — RedNite, Pomella, MenaQ7 — which is a modest point in the formula’s favour, since branded extracts are usually the ones with published characterization behind them. The catch is that per-ingredient milligram amounts are not published for a serving. With sixteen-odd ingredients in one daily serving, that is the number that decides whether this matches the research or gestures at it.

What The Research Shows

Based on articles retrieved from PubMed, the two circulation ingredients here with the most substantial human evidence are L-citrulline and beetroot nitrate.

Citrulline lowers blood pressure modestly in older adults — and works better paired with arginine. A 2025 systematic review and meta-analysis pooled 15 randomized controlled trials (24 datasets, 415 participants) of L-citrulline supplementation and watermelon intake in middle-aged and older people. Systolic pressure fell by about 4.0 mmHg and diastolic by about 2.5 mmHg versus control. In the subgroup where citrulline was combined with L-arginine, the systolic drop was considerably larger, around 10.4 mmHg. VenoPlus 8 contains both, which lines up with that finding. DOI

Beetroot nitrate has a consistent, dose-related effect — but it is small. A meta-analysis of 22 randomized trials with roughly 1,250 participants found beetroot juice lowered systolic pressure by 3.55 mmHg and diastolic by 1.32 mmHg overall, with larger effects at higher doses and study durations of two weeks or more. Interestingly, the analysis also found evidence of blood-pressure effects that were not explained by nitrate content alone, pointing to beetroot’s other polyphenols. DOI

In people who actually have hypertension, the picture is narrower than the marketing suggests. A 2024 meta-analysis restricted to adults meeting the European Society of Hypertension threshold (≥140/≥90 mmHg) found beetroot juice reduced clinic systolic pressure by 5.31 mmHg — but showed no significant effect on diastolic pressure and no significant effect on 24-hour ambulatory blood pressure, which is the measure clinicians take more seriously. The authors graded the certainty of evidence as low and told readers to interpret cautiously. That is a genuine limitation worth carrying into any purchase decision. DOI

The vitamin K2 story is thinner than the “arterial health” framing implies. MK-7 has been trialed for arterial stiffness, and the results are mixed. A multicenter randomized trial gave 375 mcg/day of MK-7 to 96 hemodialysis patients with stiff arteries for 24 weeks and found no significant difference in pulse wave velocity versus standard care overall — benefit appeared only in the diabetic subgroup. DOI A separate double-blind placebo-controlled trial in 40 vitamin K-deficient kidney transplant recipients found 360 mcg/day of MK-7 did not change serum calcification propensity, though it did prevent progression of pulse wave velocity. DOI Both trials were in patients with kidney disease and documented vitamin K deficiency — a long way from a healthy adult with a normal diet.

The Honest Verdict

What holds up: The nitric oxide premise is real physiology, not invention. Citrulline plus arginine and dietary nitrate both have pooled randomized evidence for lowering blood pressure, and combining the precursor and nitrate pathways is a defensible formulation. Effects land in the range of 3-5 mmHg systolic — meaningful at a population level, less dramatic than a sales page implies for one person.

What doesn’t: The hypertension-specific analysis found nothing on 24-hour ambulatory pressure, and rated its own certainty as low. The vitamin K2 trials were run in dialysis and transplant patients with measured deficiency, and one of them missed its primary endpoint outright — that evidence does not transfer cleanly to a general-population circulation supplement. And the undisclosed per-ingredient amounts are the real problem: trials used gram-level citrulline and 200-800 mg of nitrate. Sixteen ingredients in one scoop rarely leaves room for both at studied doses.

Who this makes sense for: Someone with blood pressure at the high end of normal who is already exercising and watching sodium, who wants a plausible additive nudge and understands the size of the nudge. Also reasonable for people who simply won’t eat beets or watermelon regularly.

Who should skip it: Anyone with diagnosed hypertension treating this as an alternative to prescribed medication — nothing here supports that. Anyone on nitrates for angina or on PDE5 inhibitors should not stack nitric-oxide boosters without talking to a prescriber, as the blood-pressure effects can compound. People on warfarin need to be especially careful, since vitamin K directly opposes that drug.

Check current pricing and availability

View VenoPlus 8 on the official site

This article is for informational purposes only and is not medical advice. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration. Talk to your physician before starting any supplement, especially if you have a diagnosed condition or take medication.

Research cited via PubMed:

  • Luo P, et al. Clin Nutr ESPEN. 2025;69:653-664. DOI
  • Bahadoran Z, et al. Adv Nutr. 2017;8(6):830-838. DOI
  • Grönroos R, et al. Nutr Metab Cardiovasc Dis. 2024;34(10):2240-2256. DOI
  • Naiyarakseree N, et al. Nutrients. 2023;15(11):2422. DOI
  • Eelderink C, et al. Am J Transplant. 2023;23(4):520-530. DOI

Leave a Reply

Your email address will not be published. Required fields are marked *